New appointments at Amarantus Therapeutics
This article was originally published in Scrip
Executive Summary
Amarantus Therapeutics, a privately held US biotechnology company developing disease-modifying treatments that address the underlying cause of cell death, has named Vern Norviel corporate secretary and has also appointed Kenneth Coleman, chairman of Accelrys, and Gene Mancino, a founding partner of the life sciences executive search firm Mancino Burfield Edgerton, to its board of directors. Mr Norviel is currently a partner at Wilson Sonsini Goodrich & Rosati, where he leads the firm's patents and innovation counselling practice.